These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 34339916
21. Effectiveness of Qingre Lishi Yishen decoction on the glomerular fibrosis of immunoglobulin A nephropathy in a rat's model. Dang W, Hou L, Wu H, Yan X, Zhen X, Hao J. J Tradit Chin Med; 2019 Aug; 39(4):516-523. PubMed ID: 32186099 [Abstract] [Full Text] [Related]
22. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC. Kidney Int; 2004 Oct; 66(4):1403-16. PubMed ID: 15458433 [Abstract] [Full Text] [Related]
23. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes. Han J, Zhang Y, Shi X, Peng Z, Xing Y, Pang X. J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205 [Abstract] [Full Text] [Related]
24. Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells. Leung JC, Chan LY, Saleem MA, Mathieson PW, Tang SC, Lai KN. Apoptosis; 2015 Jul; 20(7):907-20. PubMed ID: 25808596 [Abstract] [Full Text] [Related]
25. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway. Huang G, Lv J, Li T, Huai G, Li X, Xiang S, Wang L, Qin Z, Pang J, Zou B, Wang Y. Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993 [Abstract] [Full Text] [Related]
26. Valsartan inhibits amylin-induced podocyte damage. Huang F, Wang Q, Ma X, Wu L, Guo F, Qin G. Microvasc Res; 2016 Jul; 106():101-9. PubMed ID: 27102209 [Abstract] [Full Text] [Related]
27. Wenshen Jianpi recipe, a blended traditional Chinese medicine, ameliorates proteinuria and renal injury in a rat model of diabetic nephropathy. Cao X, Wei R, Zhou J, Zhang X, Gong W, Jin T, Chen X. BMC Complement Altern Med; 2019 Jul 30; 19(1):193. PubMed ID: 31362740 [Abstract] [Full Text] [Related]
28. The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy. Zhong Q, Leung JC, Chan LY, Tsang AW, Chen X, Lai KN. Am J Chin Med; 2005 Jul 30; 33(4):613-26. PubMed ID: 16173535 [Abstract] [Full Text] [Related]
29. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Ren Z, Liang W, Chen C, Yang H, Singhal PC, Ding G. Cell Signal; 2012 Feb 30; 24(2):443-450. PubMed ID: 21982880 [Abstract] [Full Text] [Related]
30. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria]. Guan N, Deng JH, Ding J, Zhang JJ, Yang JY. Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 30; 36(2):139-44. PubMed ID: 15100730 [Abstract] [Full Text] [Related]
31. The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte. Le Berre L, Tilly G, Pilet P, Brouard S, Dantal J. Am J Nephrol; 2024 Apr 30; 55(5):583-596. PubMed ID: 39074452 [Abstract] [Full Text] [Related]
32. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule]. Sun W, Li CQ, Chen JH, Shao JD, Zhou D, Zhang L, Gao K. Zhongguo Zhong Yao Za Zhi; 2013 Jan 30; 38(1):81-90. PubMed ID: 23596882 [Abstract] [Full Text] [Related]
33. Effects of modified Huangqi Chifeng decoction on the IL-17 signaling pathway in an IgA nephropathy rat model. Ma S, Yang B, Zhao M, Li P, Fan J, Chang M, Pan Z, Zhang Z, Xue S, Zhang Y. J Ethnopharmacol; 2023 May 10; 307():116220. PubMed ID: 36750149 [Abstract] [Full Text] [Related]
34. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats. Zhu C, Huang S, Ding G, Yuan Y, Chen Q, Pan X, Chen R, Zhang A. Pediatr Nephrol; 2011 Jun 10; 26(6):905-13. PubMed ID: 21359962 [Abstract] [Full Text] [Related]
35. The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true 'interaction' in podocyte. Fan Q, Xing Y, Ding J, Guan N, Zhang J. Kidney Int; 2006 Apr 10; 69(7):1207-15. PubMed ID: 16501493 [Abstract] [Full Text] [Related]
36. Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy. Lai KN, Chan LY, Guo H, Tang SC, Leung JC. Pediatr Nephrol; 2011 Feb 10; 26(2):257-66. PubMed ID: 21125406 [Abstract] [Full Text] [Related]
37. Protective effect of modified Huangqi Chifeng decoction on immunoglobulin A nephropathy through toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway. Liusheng LI, Mingming Z, Meiying C, Yuan SI, Jinning Z, Bin Y, Yu Z. J Tradit Chin Med; 2024 Apr 10; 44(2):324-333. PubMed ID: 38504538 [Abstract] [Full Text] [Related]
38. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Eto N, Wada T, Inagi R, Takano H, Shimizu A, Kato H, Kurihara H, Kawachi H, Shankland SJ, Fujita T, Nangaku M. Kidney Int; 2007 Aug 10; 72(4):455-63. PubMed ID: 17457371 [Abstract] [Full Text] [Related]
39. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1. Huang H, You Y, Lin X, Tang C, Gu X, Huang M, Qin Y, Tan J, Huang F. Cell Physiol Biochem; 2017 Aug 10; 41(1):163-172. PubMed ID: 28214865 [Abstract] [Full Text] [Related]
40. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy. Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H. PLoS One; 2013 Aug 10; 8(8):e73425. PubMed ID: 24023680 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]